Articles with public access mandates - Yusuf BaranLearn more
Available somewhere: 9
Sphingosine kinase-1 and sphingosine 1-phosphate receptor 2 mediate Bcr-Abl1 stability and drug resistance by modulation of protein phosphatase 2A
A Salas, S Ponnusamy, CE Senkal, M Meyers-Needham, SP Selvam, ...
Blood, The Journal of the American Society of Hematology 117 (22), 5941-5952, 2011
Mandates: US National Institutes of Health
5-Fluorouracil signaling through a calcium–calmodulin-dependent pathway is required for p53 activation and apoptosis in colon carcinoma cells
G Can, B Akpinar, Y Baran, B Zhivotovsky, M Olsson
Oncogene 32 (38), 4529-4538, 2013
Mandates: Swedish Research Council
Targeting glucosylceramide synthase sensitizes imatinib-resistant chronic myeloid leukemia cells via endogenous ceramide accumulation
Y Baran, J Bielawski, U Gunduz, B Ogretmen
Journal of cancer research and clinical oncology 137, 1535-1544, 2011
Mandates: US National Institutes of Health
HER2‐Targeted, Degradable Core Cross‐Linked Micelles for Specific and Dual pH‐Sensitive DOX Release
NN Bayram, GT Ulu, M Topuzoğulları, Y Baran, S Dinçer İşoğlu
Macromolecular Bioscience 22 (1), 2100375, 2022
Mandates: Scientific and Technological Research Council of Turkey
La médecine de précision en oncologie: challenges, enjeux et nouveaux paradigmes
S Cox, M Rousseau-Tsangaris, N Abou-Zeid, S Dalle, P Leurent, ...
Bulletin du Cancer 106 (2), 97-104, 2019
Mandates: National Institute of Health and Medical Research, France
Therapeutic potentials of inhibition of Jumonji C domain-containing demethylases in acute myeloid leukemia
D Koca, N Hastar, S Engür, Y Kiraz, GT Ulu, D Cekdemir, Y Baran
Turkish Journal of Hematology 37 (1), 5, 2020
Mandates: Scientific and Technological Research Council of Turkey
HER2-specific peptide (LTVSPWY) and antibody (herceptin) targeted core cross-linked micelles for breast cancer: A Comparative study
NN Bayram, GT Ulu, NA Abdulhadi, S Gürdap, İA İşoğlu, Y Baran, ...
Pharmaceutics 15 (3), 733, 2023
Mandates: Scientific and Technological Research Council of Turkey
3P Determination of therapeutic effects of multifunctional micelle-based nanocarriers on breast cancer cells
GT Ulu, NN Bayram, N Abdulhadi, S Gürdap, A İşoğlu, SD İşoğlu, Y Baran
Annals of Oncology 32, S1, 2021
Mandates: Scientific and Technological Research Council of Turkey
31P Advantage of co-culture strategy for targeted cancer treatment and in vitro studies
GT Ulu, NN Bayram, SD İşoğlu, Y Baran
Annals of Oncology 32, S370, 2021
Mandates: Scientific and Technological Research Council of Turkey
Publication and funding information is determined automatically by a computer program